glp-1 obesity drug news today oct 23 2025 Agonists Weight Loss Drugs Market Report, 2025-2030 GLP-1 Agonists Weight Loss Drugs
Description
New data is illuminating the full profile of GLP-1 side effects
Learn how different GLP-1 medications work, how they differ for weight loss vs diabetes and why dual agonists like tirzepatide stand out.
With the emergence of various classes of blood glucose-lowering agents, choosing the appropriate drug for each patient is emphasized in diabetes management
But from 2030, Pfizer could emerge as a credible Top-3 obesity player if both the injectable and oral combo strategies succeed
Here's how to address root causes of metabolic health and infertility for long term success.
